A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo (Q58921543)

1

0 references

Chun-Nam Lok

2

0 references

Tommy Tsz-Him Fong

3

0 references

Carrie Ka-Lei Li

4

0 references

Zhen Fan Yang

5

0 references

Taotao Zou

6

0 references

Annie Fung-Ming Siu

Metal complexes in medicine with a focus on enzyme inhibition

7

0 references

publication date

2013

0 references

published in

Chemical Science

0 references

volume

4

0 references

issue

5

0 references

page(s)

1979

0 references

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Targeting proteins with metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Antitumour metal compounds: more than theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

New metal complexes as potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Biological inorganic chemistry at the beginning of the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

The status of platinum anticancer drugs in the clinic and in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold compounds as therapeutic agents for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Latest insights into the anticancer activity of gold(III)-dithiocarbamato complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Structural and spectroscopic studies on Pt.Pt and pi-pi interactions in luminescent multinuclear cyclometalated platinum(II) homologues tethered by oligophosphine auxiliaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear d

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

The Connectivity Map: a new tool for biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Rottlerin and cancer: novel evidence and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

A gene signature-based approach identifies mTOR as a regulator of p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Roles of CHOP/GADD153 in endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Cysteine proteases as targets for metal-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Interactions of Selected Gold(III) Complexes with Calf Thymus DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Reactions of gold(III) complexes with serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Atomic structure and chemistry of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K

Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3SC21972K